9 Science-Backed Benefits Of CBD Oil – Forbes Health

sources

The Health Effects of Cannabis and Cannabinoids: The Current State of the Evidence and Recommendations for Research. Nih.gov. Accessed on May 13th, 2021.

Corroon J, Felice JF. The endocannabinoid system and its modulation by cannabidiol (CBD). Aging Ther Health Med. 2019; 25 (S2): 6-14.

Cannabidiol (CBD) – What We Know and What Not – Harvard Health Blog. Harvard Health Blog. Accessed on May 13, 2021.

Linares IM, Zuardi AW, Pereira LC, et al. Cannabidiol shows an inverted U-shaped dose-response curve in a simulated public speaking test. Brazilian Journal of Psychiatry. 2019; 41 (1): 9-14.

Zanelati TV, Biojone C, Moreira FA, Guimarães FS, Joca SR. Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors. Br J Pharmacol. 2010; 159 (1): 122-128.

Commissioner’s office. FDA approves first drug with an active ingredient derived from marijuana for the treatment of rare, severe forms of epilepsy. U.S. Food and Drug Administration. Accessed on May 13, 2021.

Elms L, Shannon S, Hughes S, Lewis N. Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series. The journal for alternative and complementary medicine. 2019; 25 (4): 392-397.

Bitencourt RM, Takahashi RN. Cannabidiol as a therapeutic alternative for post-traumatic stress disorders: From laboratory research to confirmation in human studies. Frontiers in Neuroscience. 2018; 12.

YL Hurd, S. Spriggs, J. Alishayev et al. Cannabidiol for reducing stimulus-induced desire and anxiety in drug abstinent individuals with heroin use disorder: a double-blind, randomized, placebo-controlled study. American Journal of Psychiatry. 2019; 176 (11): 911-922.

YL Hurd, M. Yoon, AF Manini, et al. Early phase of cannabidiol development for the treatment of addiction: opioid relapse is a priority. Neurotherapeutics. 2015; 12 (4): 807-815.

Bilsland LG, Dick JR, Pryce G, et al. Rising cannabinoid levels through pharmacological and genetic manipulation delay disease progression in SOD1 mice. FASEB J. 2006; 20 (7): 1003-1005.

Meyer T, Funke A, Münch C, et al. Practical experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity with tetrahydrocannabinol: cannabidiol (THC: CBD). BMC Neurol. 2019; 19 (1): 222.

Russian EB. Cannabinoids in the treatment of hard-to-treat pain. Ther Clin Risk Manag. 2008; 4 (1): 245-259.

Xu DH, Cullen BD, Tang M, Fang Y. The effectiveness of topical cannabidiol oil in symptomatic relief of peripheral neuropathy of the lower extremities. Curr Pharm Biotechnology. 2020; 21 (5): 390-402.

Weiss L, Zeira M, Reich S, et al. Cannabidiol lowers the incidence of diabetes in non-obese diabetic mice. Autoimmunity. 2006; 39 (2): 143-151.

Rajesh M, Mukhopadhyay P, Bátkai S, et al. Cannabidiol weakens inflammatory reactions of the endothelial cells and barrier disorders induced by high glucose. American Journal of Physiology-Cardiovascular Physiology. 2007; 293 (1): H610-H619.

A randomized, double-blind, placebo-controlled, parallel-group pilot study with a 1: 1 and 20: 1 ratio of formulated GWP42003: GWP42004 plus GWP42003 and GWP42004 alone in the treatment of dyslipidemia in patients with type 2 diabetes. Clinicaltrials.gov. Accessed on May 13, 2021.

Mannucci C, Navarra M, Calapai F, et al. Neurological aspects of the medical use of cannabidiol. Drug Targets for CNS Neurol Disorders. 2017; 16 (5): 541-553.

Malfait AM, Gallily R, Sumariwalla PF, et al. The non-psychoactive cannabis component cannabidiol is an oral anti-arthritic therapeutic agent for murine collagen-induced arthritis. Proc Natl Acad Sci USA. 2000; 97 (17): 9561-9566.

Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M. Cannabinoids as novel anti-inflammatory drugs. Future Med Chem. 2009; 1 (7): 1333-1349.

Blake DR, Robson P, Ho M, Jubb RW, McCabe CS. Preliminary evaluation of the effectiveness, tolerability and safety of a cannabis-based drug (Sativex) in the treatment of pain caused by rheumatoid arthritis. rheumatology. 2006; 45 (1): 50-52.

Hunter D, Oldfield G, Tich N, Messenheimer J, Sebree T. Synthetic transdermal cannabidiol used to treat knee pain in osteoarthritis. Osteoarthritis and cartilage. 2018; 26: S26.

source https://www.bisayanews.com/2021/09/19/9-science-backed-benefits-of-cbd-oil-forbes-health/